Klenke, Frank M.

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2016

Siebenrock, KA; Klenke, FM (2016). [Tumors of the musculoskeletal system: what does the family physician need to know?]. Revue médicale suisse, 12(503), pp. 223-225. Médecine & Hygiène

2015

Klenke, Frank M; Hoffmann, Daniel B; Cross, Brian J; Siebenrock, Klaus A (2015). Validation of a standardized mapping system of the hip joint for radial MRA sequencing. Skeletal radiology, 44(3), pp. 339-343. Springer 10.1007/s00256-014-2026-z

Abdelnasser, Mohammad K; Klenke, Frank M; Whitlock, Patrick; Khalil, Aly M; Khalifa, Yaser E; Ali, Hassan M; Siebenrock, Klaus A (2015). Management of pelvic discontinuity in revision total hip arthroplasty: a review of the literature. Hip International, 25(2), pp. 120-126. Wichtig Editore 10.5301/hipint.5000201

2014

Choy, John; Albers, Christoph; Siebenrock, Klaus-Arno; Dolder, Silvia; Hofstetter, Wilhelm; Klenke, Frank M. (2014). Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics. Bone, 69, pp. 80-88. Elsevier 10.1016/j.bone.2014.09.013

Klenke, Frank M.; Wirtz, Christian; Banz Wälti, Yara; Keel, Marius; Klass, Natalie Désirée; Novak, Urban; Benneker, Lorin Michael (2014). Multiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature. Global Spine Journal, 4(2), pp. 109-114. Thieme 10.1055/s-0033-1360724

2013

Albers, Christoph E; Hofstetter, Wilhelm; Siebenrock, Klaus A; Landmann, Regine; Klenke, Frank M. (2013). In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology, 7(1), pp. 30-36. London: Informa Healthcare 10.3109/17435390.2011.626538

Montjovent, Marc-Oliver; Siegrist, Mark; Klenke, Frank M; Wetterwald, Antoinette; Dolder, Silvia; Hofstetter, Wilhelm (2013). Expression of antagonists of WNT and BMP signaling after non-rigid fixation of osteotomies. Bone, 53(1), pp. 79-86. New York, N.Y.: Elsevier 10.1016/j.bone.2012.11.027

Choy, John; Hofstetter, Wilhelm; Klenke, Frank M. (2013). RANKL immobilized on β-TCP induces and maintains osteoclast formation. Bone Abstracts, 1, PP227. Bioscientifica 10.1530/boneabs.1.PP227

2012

Klenke, F M; Evangelopoulos, D S; Zimmermann, H; Exadaktylos, A K (2012). Full-body low radiation radiography (Lodox)-A safe drug detection device in body packers? Injury - international journal of the care of the injured, 43(7), pp. 1231-3. Oxford: Elsevier 10.1016/j.injury.2011.07.002

Albers, Christoph E; Hofstetter, Wilhelm; Sebald, Hans-Jörg; Sebald, Walter; Siebenrock, Klaus A; Klenke, Frank M (2012). L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin. Bone, 51(3), pp. 401-6. New York, N.Y.: Elsevier 10.1016/j.bone.2012.06.020

Klenke, Frank M; Siebenrock, Klaus A (2012). Pathomorphology and treatment of femoroacetabular impingement. Instructional course lectures, 61, pp. 263-272. St. Louis, Mo.: Mosby

Sebald, Hans-Jörg; Klenke, Frank M; Siegrist, Mark; Albers, Christoph E; Sebald, Walter; Hofstetter, Wilhelm (2012). Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing. Acta biomaterialia, 8(10), pp. 3816-20. Amsterdam: Elsevier 10.1016/j.actbio.2012.06.036

2011

Krieg, A H; Hefti, F; Speth, B M; Jundt, G; Guillou, L; Exner, U G; von Hochstetter, A R; Cserhati, M D; Fuchs, B; Mouhsine, E; Kaelin, A; Klenke, F M; Siebenrock, K A (2011). Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Annals of oncology, 22(2), pp. 458-67. Oxford: Oxford University Press 10.1093/annonc/mdq394

Verdegaal, Suzan H M; Bovée, Judith V M G; Pansuriya, Twinkal C; Grimer, Robert J; Ozger, Harzem; Jutte, Paul C; San Julian, Mikel; Biau, David J; van der Geest, Ingrid C M; Leithner, Andreas; Streitbürger, Arne; Klenke, Frank M; Gouin, Francois G; Campanacci, Domenico A; Marec-Berard, Perrine; Hogendoorn, Pancras C W; Brand, Ronald; Taminiau, Antonie H M (2011). Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist, 16(12), pp. 1771-9. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2011-0200

Klenke, Frank Michael; Abdollahi, Amir; Bischof, Marc; Gebhard, Martha-Maria; Ewerbeck, Volker; Huber, Peter E; Sckell, Axel (2011). Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. Strahlentherapie und Onkologie, 187(1), pp. 45-51. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-010-2116-3

Klenke, Frank M; Wenger, Doris E; Inwards, Carrie Y; Rose, Peter S; Sim, Franklin H (2011). Recurrent giant cell tumor of long bones: analysis of surgical management. Clinical orthopaedics and related research, 469(4), pp. 1181-7. Heidelberg: Springer 10.1007/s11999-010-1560-9

Klenke, Frank M; Wenger, Doris E; Inwards, Carrie Y; Rose, Peter S; Sim, Franklin H (2011). Giant cell tumor of bone: risk factors for recurrence. Clinical orthopaedics and related research, 469(2), pp. 591-9. Heidelberg: Springer 10.1007/s11999-010-1501-7

2010

Wernike, E; Montjovent, MO; Liu, Y; Wismeijer, D; Hunziker, EB; Siebenrock, KA; Hofstetter, W; Klenke, FM (2010). VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. European cells & materials eCM, 19, pp. 30-40. Aberystwyth (UK): University of Wales

Wernike, E; Hofstetter, W; Liu, Y; Wu, G; Sebald, HJ; Wismeijer, D; Hunziker, EB; Siebenrock, KA; Klenke, FM (2010). Long-term cell-mediated protein release from calcium phosphate ceramics. Journal of biomedical materials research, 92(2), pp. 463-74. Hoboken, N.J.: John Wiley & Sons 10.1002/jbm.a.32411

2009

Sckell, A; Klenke, FM (2009). The cranial bone window model: studying angiogenesis of primary and secondary bone tumors by intravital microscopy. Methods in molecular biology, 467, pp. 343-355. Totowa, N.J.: Humana Press 10.1007/978-1-59745-241-0_22

2008

Klenke, FM; Liu, Y; Yuan, H; Hunziker, EB; Siebenrock, KA; Hofstetter, W (2008). Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. Journal of biomedical materials research. Part A, 85(3), pp. 777-86. Hoboken, N.J.: John Wiley & Sons 10.1002/jbm.a.31559

2007

Klenke, Frank M; Abdollahi, Amir; Bertl, Elisabeth; Gebhard, Martha-Maria; Ewerbeck, Volker; Huber, Peter E; Sckell, Axel (2007). Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC cancer, 7, p. 49. London: BioMed Central 10.1186/1471-2407-7-49

2006

Klenke, Frank Michael; Gebhard, Martha-Maria; Ewerbeck, Volker; Abdollahi, Amir; Huber, Peter E; Sckell, Axel (2006). The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC cancer, 6, p. 9. London: BioMed Central 10.1186/1471-2407-6-9

Klenke, FM; Liu, Y; Siebenrock, KA; Hofstetter, W (2006). The biological properties of calcium phosphate bone substitutes are influenced by the biomaterials pore size. Transactions - European Orthopaedic Research Society(16), O86. Lausanne: Presses Polytechniques et Universitaires Romandes

Provide Feedback